Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
Status:
Completed
Trial end date:
2012-08-24
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine patterns of brain activity in people who are at risk
for memory problems (e.g., Alzheimer's disease or dementia)before and after the medication
donepezil. Although genetic testing will be done, the results will not be shared with study
participants.
Once the genetic testing is completed subjects may continue to the second phase of the study.
During this time they will be asked to take the medication donepezil (which is approved by
the FDA for the treatment of Alzheimer's disease).
Donepezil is not FDA approved for healthy volunteers and is therefore considered
investigational in this study.
Phase:
Phase 1
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center